These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23751329)

  • 1. Shuffling Adaptive Clinical Trials.
    Gokhale SG; Gokhale S
    Am J Ther; 2016; 23(3):e663-9. PubMed ID: 23751329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive design of confirmatory trials: Advances and challenges.
    Lai TL; Lavori PW; Tsang KW
    Contemp Clin Trials; 2015 Nov; 45(Pt A):93-102. PubMed ID: 26079372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive methods: when and how should they be used in clinical trials?
    Porcher R; Lecocq B; Vray M;
    Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern study designs and analysis methods in clinical research].
    Gerß J; Eveslage M; Faldum A; Schmidt R
    Z Rheumatol; 2015 Mar; 74(2):106-12. PubMed ID: 25805512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Bayesian modeling in frequentist adaptive enrichment designs.
    Simon N; Simon R
    Biostatistics; 2018 Jan; 19(1):27-41. PubMed ID: 28520893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory view of adaptive trial design.
    Wang M; Wu YC; Tsai GF
    J Formos Med Assoc; 2008 Dec; 107(12 Suppl):3-8. PubMed ID: 19129039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive designs: The Swiss Army knife among clinical trial designs?
    Bretz F; Gallo P; Maurer W
    Clin Trials; 2017 Oct; 14(5):417-424. PubMed ID: 28982262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical consideration of adaptive methods in clinical development.
    Chow SC; Chang M; Pong A
    J Biopharm Stat; 2005; 15(4):575-91. PubMed ID: 16022164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive designs for confirmatory clinical trials.
    Bretz F; Koenig F; Brannath W; Glimm E; Posch M
    Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive design methods in clinical trials - a review.
    Chow SC; Chang M
    Orphanet J Rare Dis; 2008 May; 3():11. PubMed ID: 18454853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group.
    Phillips AJ; Keene ON;
    Pharm Stat; 2006; 5(1):61-6. PubMed ID: 17080929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Bayesian adaptive trials when treatment efficacy depends on biomarkers.
    Zhang Y; Trippa L; Parmigiani G
    Biometrics; 2016 Jun; 72(2):414-21. PubMed ID: 26575199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical innovations in the medical device world sparked by the FDA.
    Campbell G; Yue LQ
    J Biopharm Stat; 2016; 26(1):3-16. PubMed ID: 26372890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive clinical trial design.
    Chow SC
    Annu Rev Med; 2014; 65():405-15. PubMed ID: 24422576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
    Atkinson AC; Biswas A
    Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
    Chen MH; Willan AR
    Clin Trials; 2013 Feb; 10(1):54-62. PubMed ID: 23263520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some challenges with statistical inference in adaptive designs.
    Hung HM; Wang SJ; Yang P
    J Biopharm Stat; 2014; 24(5):1059-72. PubMed ID: 24915027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.